Visser, K <br/><br/>
A matrix risk model for the prediction of rapid radiographic progression in patients with rheumatoid arthritis receiving different dynamic treatment strategies: post hoc analyses from the BeSt study.  [electronic resource] 

 -  Annals of the rheumatic diseases  Jul 2010 
 - 1333-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1468-2060 
<br/><br/><label>Standard No.: </label>10.1136/ard.2009.121160  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antibodies, Monoclonal--therapeutic use<br/>Antirheumatic Agents--therapeutic use<br/>Arthritis, Rheumatoid--diagnostic imaging<br/>Autoantibodies--blood<br/>C-Reactive Protein--metabolism<br/>Disease Progression<br/>Drug Therapy, Combination<br/>Epidemiologic Methods<br/>Female<br/>Glucocorticoids--therapeutic use<br/>Humans<br/>Infliximab<br/>Male<br/>Methotrexate--therapeutic use<br/>Middle Aged<br/>Peptides, Cyclic--immunology<br/>Prednisone--therapeutic use<br/>Radiography<br/>Rheumatoid Factor--blood